Semaglutide is a long-acting agonist of the GLP-1 (glucagon-like peptide-1) receptor. Its extended activity profile has made it one of the most-studied single-receptor incretin agonists in metabolic research.
Research context
Researchers use semaglutide to study GLP-1 receptor signaling and its role in glucose regulation and satiety pathways within controlled models. For how it compares with the dual-agonist tirzepatide, see Semaglutide vs Tirzepatide.
Molecular identity
Semaglutide has the molecular formula C187H291N45O59 and ships as a lyophilized powder at ≥98% HPLC purity with batch-specific documentation.
How it's supplied
Supplied in research quantities for reconstitution per a validated protocol. Product page: Semaglutide research vials.
Research Use Only. V8 Peptides products are supplied strictly for laboratory research and development and are not intended for human or veterinary use, consumption, or any therapeutic or diagnostic purpose.